Staar Surgical Co (STAA) is a publicly traded Healthcare sector company. As of September 2, 2026, STAA trades at $23.12 with a market cap of $1.18B and a P/E ratio of -14.43. STAA moved -1.74% today. Year to date, STAA is -2.08%; over the trailing twelve months it is -15.41%. Its 52-week range spans $13.50 to $35.87. Analyst consensus is neutral with an average price target of $29.67. Rallies surfaces STAA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks hedge fund and 13F ownership for STAA, including fund holders, share counts, and position changes when data is available.
| Metric | Value |
|---|---|
| Price | $23.12 |
| Market Cap | $1.18B |
| P/E Ratio | -14.43 |
| EPS | $-1.62 |
| Dividend Yield | 0.00% |
| 52-Week High | $35.87 |
| 52-Week Low | $13.50 |
| Volume | 356.74K |
| Avg Volume | 0 |
| Revenue (TTM) | $239.44M |
| Net Income | $-80.45M |
| Gross Margin | 76.19% |
8 analysts cover STAA: 0 strong buy, 2 buy, 5 hold, 1 sell, 0 strong sell. Consensus rating is neutral. Average price target: $29.67.